Natriumoxibat Kalceks (Sodium Oxybate)

Sodium Oxybate, the active ingredient in Natriumoxibat Kalceks, is a gamma‑hydroxybutyrate (GHB) CNS depressant presented as an oral formulation for oral use. It is indicated for the treatment of narcolepsy with cataplexy and excessive daytime sleepiness in adult patients.

GNH USA supplies Natriumoxibat Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Sodium Oxybate acts on the central nervous system to improve sleep architecture and reduce cataplexy episodes in narcolepsy. - Narcolepsy with cataplexy: decreases the frequency and severity of cataplectic attacks. - Excessive daytime sleepiness: enhances nighttime restorative sleep, reducing daytime sleep propensity. - Cataplexy: stabilises muscle tone during emotional triggers, improving daily functioning.

Sodium Oxybate may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Vomiting: occasional emesis. - Insomnia: difficulty maintaining sleep. - Weight loss: reduced appetite.

Serious or Rare Side Effects: - Respiratory depression: reduced breathing effort, potentially life‑threatening. - Severe hypotension: marked drop in blood pressure. - Seizures: rare convulsive episodes. - Abuse potential: risk of dependence due to GHB activity. - Allergic reactions: rash, pruritus, or anaphylaxis. - Coma: profound CNS depression in overdose.

Sodium Oxybate requires careful monitoring due to its CNS depressant properties. - Assess respiratory function: monitor for signs of depression, especially after dose initiation. - Avoid alcohol: concurrent use can potentiate sedation and respiratory risk. - Use with caution in renal impairment: reduced clearance may increase exposure. - Pregnancy considerations: limited data; weigh maternal benefit against potential fetal risk. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Sodium Oxybate can interact with other CNS depressants and certain cardiovascular agents.

Major Interactions (Avoid): - Alcohol: additive CNS depression leading to severe respiratory compromise. - Benzodiazepines: synergistic sedative effect, increasing risk of profound sedation. - Opioids: combined depressant action may cause respiratory failure.

Moderate Interactions (Monitor Closely): - Antihypertensives: potential for enhanced hypotensive effect. - Anticonvulsants: may alter seizure threshold; monitor seizure control. - Other GHB‑containing products: cumulative exposure can increase toxicity.